Form 4: Strata Critical Medical Officer's Stock Transactions

Strata Critical Medical's Chief Accounting Officer, Amir Cohen, reported the acquisition and subsequent tax-related disposition of company stock.

Summary

• Amir Cohen, Chief Accounting Officer of Strata Critical Medical, Inc. (SRTA), reported transactions involving Class A common stock.
• On October 31, 2025, Cohen acquired 41,786 shares of Class A common stock at a price of $0.
• These shares were acquired due to the satisfaction of performance criteria for performance-based restricted stock units (PSUs) granted on March 8, 2024.
• On November 3, 2025, 20,497 shares were disposed of at $5.03 per share.
• This disposition was to satisfy tax withholding obligations related to the vesting of the PSUs.
• Following these transactions, Cohen beneficially owns 121,342 shares of Class A common stock directly.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transactions are routine for executive compensation, indicating performance criteria were met, but a significant portion was sold for taxes. No major positive or negative implications for the company's operations or outlook.

Positives

• The acquisition of shares indicates the satisfaction of performance criteria for performance-based restricted stock units (PSUs), suggesting the reporting person met specific company goals.
• The shares were acquired at a $0 price, indicating they were part of a compensation package.

Negatives

• A significant portion of the acquired shares (20,497 out of 41,786) was immediately disposed of to cover tax obligations, which is a common practice but reduces the net shares retained by the officer.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Acquisition of 41,786 shares of Class A common stock from the issuer as part of performance-based restricted stock unit (PSU) vesting.
• Disposition of 20,497 shares of Class A common stock to the issuer for tax withholding obligations related to PSU vesting.

Stakeholder Impact

• Shareholders: The transactions represent routine executive compensation, which is a standard operational cost. The vesting of PSUs indicates the achievement of performance criteria, which can be viewed positively. The tax-related sale is a common occurrence and does not typically signal a change in company fundamentals.

Key Dates

Recommendation

The Form 4 details routine compensation-related stock transactions for a Chief Accounting Officer, involving the vesting of performance-based restricted stock units and subsequent tax withholding. These transactions are standard and do not provide sufficient new information to warrant a change in investment recommendation for Strata Critical Medical, Inc. The activity reflects executive compensation mechanics rather than a discretionary investment decision or a signal about the company's fundamental value.

Keywords

Strata Critical Medical, SRTA, Amir Cohen, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, PSUs, Chief Accounting Officer, Equity Compensation